Vivek Ramaswamy’s Former Company Is Doing Just Fine Without Him

Roivant wouldn’t be where it is without the Republican presidential candidate, but his departure has made…

Amgen Could Get a Piece of the Obesity Market

Amgen has a couple of shots on goal to break into one of the biggest markets…

WSJ News Exclusive | The Hedge Fund That Made a Killing Betting Against Lina Khan

Pentwater Capital predicted that FTC efforts to block big deals would fail.

Blockbuster Cancer Treatment Stymied by Supply Chain—for Now

A cell therapy for multiple myeloma promises to be a major blockbuster for J&J and partner…

Biden FTC’s Antitrust Bark Proves Worse Than Its Bite

The FTC settlement with Amgen will pave the way for more healthcare deal making.

Amgen’s $27.8 Billion Deal for Horizon Therapeutics Clears Key Hurdle

The Federal Trade Commission said it had agreed to end its legal challenge of the $27.8…

FTC Pauses Challenge to Amgen’s $27.8 Billion Deal for Horizon Therapeutics

The move gives the agency time to weigh a settlement that would allow the deal to…

VinFast, Arm and Other Index Orphans Miss Out on Billions From Passive Investors

VinFast, the Vietnamese electric-vehicle maker, and Arm, a British chip designer, are caught in a weird…